162 related articles for article (PubMed ID: 37802617)
1. Classification of post COVID-19 condition symptoms: a longitudinal study in the Belgian population.
Nayani S; Castanares-Zapatero D; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Cornelissen L; Devleesschauwer B; De Ridder K; Charafeddine R; Smith P
BMJ Open; 2023 Oct; 13(10):e072726. PubMed ID: 37802617
[TBL] [Abstract][Full Text] [Related]
2. Post COVID-19 condition and health-related quality of life: a longitudinal cohort study in the Belgian adult population.
Smith P; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Cornelissen L; Devleesschauwer B; De Ridder K; Charafeddine R
BMC Public Health; 2023 Jul; 23(1):1433. PubMed ID: 37495947
[TBL] [Abstract][Full Text] [Related]
3. Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population.
Thi Khanh HN; Cornelissen L; Castanares-Zapatero D; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Devleesschauwer B; De Ridder K; Charafeddine R; Smith P
BMC Infect Dis; 2023 Nov; 23(1):774. PubMed ID: 37940843
[TBL] [Abstract][Full Text] [Related]
4. Anxiety and depression in people with post-COVID condition: a Belgian population-based cohort study three months after SARS-CoV-2 infection.
D'Hondt S; Gisle L; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Cornelissen L; De Ridder K; Charafeddine R; Smith P
Soc Psychiatry Psychiatr Epidemiol; 2024 May; ():. PubMed ID: 38819519
[TBL] [Abstract][Full Text] [Related]
5. Post COVID-19 condition and its physical, mental and social implications: protocol of a 2-year longitudinal cohort study in the Belgian adult population.
Smith P; Proesmans K; Van Cauteren D; Demarest S; Drieskens S; De Pauw R; Cornelissen L; De Ridder K; Charafeddine R
Arch Public Health; 2022 Jun; 80(1):151. PubMed ID: 35659364
[TBL] [Abstract][Full Text] [Related]
6. Multidimensional Sleep Health Prior to SARS-CoV-2 Infection and Risk of Post-COVID-19 Condition.
Wang S; Huang T; Weisskopf MG; Kang JH; Chavarro JE; Roberts AL
JAMA Netw Open; 2023 May; 6(5):e2315885. PubMed ID: 37252741
[TBL] [Abstract][Full Text] [Related]
7. Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study.
Dryden M; Mudara C; Vika C; Blumberg L; Mayet N; Cohen C; Tempia S; Parker A; Nel J; Perumal R; Groome MJ; Conradie F; Ndjeka N; Sigfrid L; Merson L; Jassat W
Lancet Glob Health; 2022 Sep; 10(9):e1247-e1256. PubMed ID: 35961348
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Characteristics Associated With Post-COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults.
Selvakumar J; Havdal LB; Drevvatne M; Brodwall EM; Lund Berven L; Stiansen-Sonerud T; Einvik G; Leegaard TM; Tjade T; Michelsen AE; Mollnes TE; Lund-Johansen F; Holmøy T; Zetterberg H; Blennow K; Sandler CX; Cvejic E; Lloyd AR; Wyller VBB
JAMA Netw Open; 2023 Mar; 6(3):e235763. PubMed ID: 36995712
[TBL] [Abstract][Full Text] [Related]
9. Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post-COVID-19 Condition.
Liu TC; Yoo SM; Sim MS; Motwani Y; Viswanathan N; Wenger NS
JAMA Netw Open; 2023 May; 6(5):e2311974. PubMed ID: 37145596
[TBL] [Abstract][Full Text] [Related]
10. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
Xie Y; Choi T; Al-Aly Z
JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2-infection.
Jacobs LMC; Wintjens MSJN; Nagy M; Willems L; Ten Cate H; Spronk HMH; van Kuijk SMJ; Ghossein-Doha C; Netea MG; Groh LA; van Petersen AS; Warlé MC
Front Immunol; 2023; 14():1182182. PubMed ID: 37868959
[TBL] [Abstract][Full Text] [Related]
12. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study.
Ballouz T; Menges D; Anagnostopoulos A; Domenghino A; Aschmann HE; Frei A; Fehr JS; Puhan MA
BMJ; 2023 May; 381():e074425. PubMed ID: 37257891
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study.
Morello R; Mariani F; Mastrantoni L; De Rose C; Zampino G; Munblit D; Sigfrid L; Valentini P; Buonsenso D
EClinicalMedicine; 2023 May; 59():101961. PubMed ID: 37073325
[TBL] [Abstract][Full Text] [Related]
15. Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection.
Hedberg P; Granath F; Bruchfeld J; Askling J; Sjöholm D; Fored M; Färnert A; Naucler P
J Intern Med; 2023 Feb; 293(2):246-258. PubMed ID: 36478477
[TBL] [Abstract][Full Text] [Related]
16. Digital Patient Reported Outcome Measures Platform for Post-COVID-19 Condition and Other Long-Term Conditions: User-Centered Development and Technical Description.
Sivan M; Rocha Lawrence R; O'Brien P
JMIR Hum Factors; 2023 Oct; 10():e48632. PubMed ID: 37665334
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition.
Limoges MA; Quenum AJI; Chowdhury MMH; Rexhepi F; Namvarpour M; Akbari SA; Rioux-Perreault C; Nandi M; Lucier JF; Lemaire-Paquette S; Premkumar L; Durocher Y; Cantin A; Lévesque S; Dionne IJ; Menendez A; Ilangumaran S; Allard-Chamard H; Piché A; Ramanathan S
Front Immunol; 2023; 14():1223936. PubMed ID: 37809081
[TBL] [Abstract][Full Text] [Related]
19. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH;
JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247
[TBL] [Abstract][Full Text] [Related]
20. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
